Dow Down 0.62% Nasdaq Down 1.14%

More On GLENMARK.NS

Quotes

Charts

News & Info

Company

Analyst Coverage

  • Analyst Opinion
  • Analyst Estimates

Ownership

  • Major Holders
  • Insider Transactions
  • Insider Roster

Financials

Glenmark Pharmaceuticals Ltd. (GLENMARK.NS)

-NSE
707.70 Down 30.45(4.13%) 5:59AM EDT
Prev Close:738.15
Open:742.75
Bid:707.70
Ask:N/A
1y Target Est:N/A
Beta:N/A
Next Earnings Date:N/A
Day's Range:702.80 - 751.55
52wk Range:487.60 - 790.00
Volume:365,635
Avg Vol (3m):677,207
Market Cap:191.94B
P/E (ttm):35.39
EPS (ttm):20.00
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in INR.

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):3.23
Ex-Dividend Date:N/A

Analysts

Annual EPS Est () :N/A
Quarterly EPS Est () :N/A
Mean Recommendation*:N/A
PEG Ratio (5 yr expected):N/A

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Glenmark Pharmaceuticals Limited, together with its subsidiaries, develops, manufactures, and markets pharmaceutical products. The company’s products include Crofelemer, an anti diarrheal drug for symptomatic relief of non-infectious diarrhoe... View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback